Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
May 01  •  04:00PM ET
0.3527
Dollar change
-0.0101
Percentage change
-2.80
%
Index
-
P/E
-
EPS (ttm)
-0.32
Insider Own
51.40%
Shs Outstand
17.05M
Perf Week
-5.71%
Market Cap
6.01M
Forward P/E
-
EPS next Y
-
Insider Trans
0.00%
Shs Float
8.29M
Perf Month
8.18%
Enterprise Value
5.22M
PEG
-
EPS next Q
-
Inst Own
1.43%
Perf Quarter
-26.01%
Income
-5.10M
P/S
11.56
EPS this Y
-
Inst Trans
-24.18%
Perf Half Y
-45.31%
Sales
0.52M
P/B
0.82
EPS next Y
-
ROA
-64.45%
Perf YTD
-16.19%
Book/sh
0.43
P/C
2.05
EPS next 5Y
-
ROE
-82.84%
52W High
32.00 -98.90%
Perf Year
-90.84%
Cash/sh
0.17
P/FCF
-
EPS past 3/5Y
- -
ROIC
-83.26%
52W Low
0.25 40.33%
Perf 3Y
-
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
-8.37% -7.12%
Gross Margin
62.59%
Volatility
16.09% 11.82%
Perf 5Y
-
Dividend TTM
-
EV/Sales
10.04
EPS Y/Y TTM
-591.09%
Oper. Margin
-991.71%
ATR (14)
0.05
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
8.72
Sales Y/Y TTM
16.70%
Profit Margin
-974.68%
RSI (14)
52.60
Recom
-
Dividend Gr. 3/5Y
- -
Current Ratio
8.83
EPS Q/Q
-592.40%
SMA20
8.18%
Beta
3.18
Target Price
-
Payout
-
Debt/Eq
0.02
Sales Q/Q
91.63%
SMA50
5.45%
Rel Volume
0.02
Prev Close
0.36
Employees
-
LT Debt/Eq
0.00
Earnings
-
SMA200
-77.18%
Avg Volume
3.30M
Price
0.35
IPO
Sep 05, 2024
Option/Short
No / Yes
EPS/Sales Surpr.
- -
Trades
Volume
59,712
Change
-2.80%
iTonic Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.